Healthcare industry

Article - 31/05/2017

Peritoneal cancer – long-term survival with good quality of life

Thanks to an innovative treatment procedure that has been in use since 2005, surgeons from Tübingen University Hospital have been able to prolong the survival of patients with peritoneal cancer and give them a higher quality of life. This is done using a technique based on complex surgery followed by immediate intraoperative local chemotherapy on the peritoneum.

Article - 23/03/2017

CeMIT – professional innovation management for the medical device sector

With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…

Article - 04/10/2016

Distance learning course in molecular biology – from lab to studies

In cooperation with the University of Mainz, the Springer publishing house is now offering distance learning courses for laboratory and technical assistants who wish to study while they are working. The courses lead to a Bachelor of Science degree. The successful programme for ambitious non-academics is being developed in several Baden-Württemberg cities.

Dossier - 26/11/2012

Genetic diagnostics: technology reaches the limits of what is medically reasonable

Rapid progress in sequencing technologies is poised to set the imagination of biomedical researchers on fire. Experts now believe that progress is about to make possible what seemed to be utopian a few years ago – it seems likely that it will soon be possible to sequence the human genome in only a few minutes and store and automatically analyse it using tiny automates. However, is everything that is technically feasible also reasonable?

Article - 09/07/2012

Bachelor’s and master’s graduates – what really counts is individual aptitude

Ravensburg-based Vetter Pharma GmbH has been constantly growing over the last few years; the company took on 300 new staff in 2011 and plans to recruit 350 more in 2012. The company is desperately looking for qualified young people to help manage its growth. In what way does this impact on job opportunities for bachelor’s and master’s graduates? In the following interview, Christiane Priebe, Director of Human Resources at Vetter Pharma, talks…

Press release - 19/03/2012

New degree course to train cluster managers

The new Franco-German “Cluster and Regional Networks Management” master’s programme will be launched in the 2012/2013 winter semester. This course is unique in Europe and was unveiled by the Universities of Strasbourg and Kehl in Strasbourg on 7th March 2012. An additional initiative by BIOPRO Baden-Württemberg will provide further training options running alongside the new master’s programme that will allow people to follow a degree course while…

Press release - 14/03/2012

Three cluster regions with a common goal

At MEDTEC Europe 2012, the leading medical platform in Europe held in Stuttgart from 13th to 15th March 2012, the three life sciences organisations BIOPRO Baden-Württemberg GmbH, Health Technology Cluster – Clusterland Oberösterreich GmbH and Human.technology Styria GmbH signed a “Memorandum of Understanding (MoU”) to seal their future cooperation.

Article - 25/07/2011

Cell culture technology: hamster cells and the production of biopharmaceuticals

Biopharmaceuticals are one of the best selling drugs. The majority of successful biopharmaceutical ingredients are produced in CHO cell lines. Strong competition forces biopharmaceutical producers to continuously improve the drug development process and the production methods, which requires highly qualified experts.

Article - 30/08/2010

A centre focusing on hepatocellular carcinoma research

Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer.

Article - 30/08/2010

Bodensee Brustzentrum offers effective breast cancer prevention services

The two Brustzentrum Bodensee (Lake Constance Breast Centre) sites at the Hospital in Constance and the Women’s Hospital in Friedrichshafen have a principal goal: to enable the best possible early detection of all types of breast cancer, to reduce the morbidity and mortality of breast cancer patients and to increase survival rates by offering ultra-modern breast cancer prevention measures.

Press release - 18/02/2010

New “Advanced Oncology” course at the University of Ulm

The Advanced Oncology course is a new further training course that will be offered by the University of Ulm from the 2010 winter semester. The course will be taught in English and is designed to extend postgraduates skills in oncology and other areas at the highest academic level. The course gives the participants the scope to adapt the training to their individual requirements.

Article - 14/11/2009

"A little naivety always helps"

The biotech company CureVac based in Tuebingen is working on the development of a new tumour therapy based on RNA molecules. Dr. Ingmar Hoerr one of the scientists who founded CureVac tells Christoph Bächtle about the obstacles the young company had to overcome and the tough decisions that led to success. At the very start he tells us the company owes its origins to a huge dollop of luck.

Article - 28/10/2009

Worn down and financially exhausted, but more popular than ever

When academic toxicologists in a German state join forces, it is virtually headline news. This is because the discipline is on the red list. Only in Baden-Württemberg does the number of toxicologists at university institutes justify the joining of forces. The ironic thing about this is that the competence of the rare species ”toxicologicus” is in greater demand than ever.

Press release - 22/06/2009

Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN)

The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…

The Konstanz Research School of Chemical Biology has just launched the third call for students from the fields of biology chemistry or related sciences to start their doctoral thesis in April 2009.

The medical online learning programme by the Tübingen-based E-learning publisher INMEDEA GmbH simulates procedures and situations in different departments of a hospital with their respective typical patient groups.